Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

Offices

San Francisco, USA
One Ferry Building
Suite 255
San Francisco, CA, 94111
USA

People

Managing Director
Managing Director
Managing Director
CFO
Principal
Principal
Office Manager
Executive Assistant

Tags

Montreux Equity Partners

Montreux Equity Partners is a private investment firm dedicated to building the leading healthcare companies of tomorrow. Our portfolio companies meet the most compelling domestic and global healthcare needs. We currently have over $440 million under management.

Since 1993, we have invested in more than 50 companies across the healthcare industry. We focus on commercial stage companies that possess highly differentiated products and services. At the time of investment, a company will typically have $5 to $50 million in revenues. We typically invest $10-20 million per company, and our capital fuels product expansion, new market entry, and strategic acquisitions.

We have a cohesive team that works closely together across all aspects of the investment process, from diligence, to investment decisions, to portfolio management. Our team is complementary with unique operational, financial, and clinical expertise. We leverage this expertise through active support of our investments.

Recent Milestones

Investments

Company Date Round Size Participants
Epirus Biopharmaceuticals 4/2014Series B$36M5
GC Aesthetics 2/2014Private Equity$60M3
MINDBODY 2/2014Private Equity$50M5
Colorescience 6/2013Series A$10M2
Glaukos 2/2013Series F$30M7
Epirus Biopharmaceuticals 7/2012Venture Round$5M2
Epirus Biopharmaceuticals 4/2012Venture Round$8.08M2
Pulmonx 1/2012Private Equity$10M5
Pivot Medical 11/2011Series C$32M4
SI-BONE 9/2011Venture Round$16M2
GC Aesthetics 10/2010Venture Round$30M1
Tobira Therapeutics 9/2010Series B$31M5
Avantis Medical Systems 6/2010Debt$2.81M1
Pulmonx 3/2010Series C$32M7
Glaukos 8/2008Series D$35M7
Pulmonx 5/2007Series B$20M4
Transcept Pharmaceuticals 3/2007Series D$40M8
Avantis Medical Systems 11/2006Series B$12M2

Videos

Sources

  1. Epirus Closes $36 Million Series B Financing (businesswire.com) [edit]
  2. GC Aesthetics raises $60M to Fund Global Growth and New Product Development (newswire.ca) [edit]
  3. Mindbody Raises $50M in Funding (finsmes.com) [edit]
  4. SkinMedica Spin-Out Colorescience Raises $10M Series A (pevc.dowjones.com) [edit]
  5. Glaukos Spots $30M for Eyeball Stent, Doesn't Blink in Ivantis Rivalry (pevc.dowjones.com) [edit]
  6. VC Funding: Q3 2012 source [edit]
  7. VC Funding: Q2 2012 source [edit]
  8. Pulmonx Raises US$10 Million In Series D Financing (researchviews.com) [edit]
  9. Pivot Medical Raises $32M in Series C Financing (finsmes.com) [edit]
  10. SI-BONE Closes $16.0M Financing Round (finsmes.com) [edit]
  11. GC Aesthetics Secures $30 Million in Financing from Montreux Equity Partners (gcaesthetics.com) [edit]
  12. Tobira Therapeutics Inc. Raises $31 Million in Series B Financing (tobiratherapeutics.com) [edit]
  13. SEC (sec.gov) [edit]
  14. Pulmonx, Inc.: Series C $32M (onbiovc.com) [edit]
  15. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
  16. Lung-device maker Pulmonx draws in $20M (venturebeat.com) [edit]
  17. Insomnia drug company, TransOral, raises $40M more (venturebeat.com) [edit]
  18. Cancer treatment co., Avantis Medical, gets $12M (venturebeat.com) [edit]
Edit This Page
Last Edited 4/16/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy